Edgewise Therapeutics Inc
(EWTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -117,579 | -76,913 | -40,798 | -133,813 | -94,151 |
| Depreciation Amortization | -4,491 | -3,005 | -1,369 | -10,255 | -8,282 |
| Accounts payable and accrued liabilities | 575 | 2,707 | 2,858 | 1,737 | 1,645 |
| Other Working Capital | -8,031 | -7,322 | -4,758 | 10,328 | 3,387 |
| Other Operating Activity | 24,302 | 14,085 | 6,201 | 22,975 | 15,330 |
| Operating Cash Flow | $-105,224 | $-70,448 | $-37,866 | $-109,028 | $-82,071 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -183 | -94 | -44 | -1,312 | -1,038 |
| Purchase Of Investment | -133,821 | -156,824 | -122,180 | -477,055 | -217,260 |
| Sale Of Investment | 51,452 | 38,650 | 166,122 | 293,711 | 12,720 |
| Investing Cash Flow | $-82,552 | $-118,268 | $43,898 | $-184,656 | $-205,578 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 192,113 | 190,454 | 2,261 | 249,515 | 246,620 |
| Other Financing Activity | 0 | 0 | -38 | -262 | -262 |
| Financing Cash Flow | $192,113 | $190,454 | $2,223 | $249,253 | $246,358 |
| Beginning Cash Position | 41,666 | 41,666 | 41,666 | 86,097 | 86,097 |
| End Cash Position | 46,003 | 43,404 | 49,921 | 41,666 | 44,806 |
| Net Cash Flow | $4,337 | $1,738 | $8,255 | $-44,431 | $-41,291 |
| Free Cash Flow | |||||
| Operating Cash Flow | -105,224 | -70,448 | -37,866 | -109,028 | -82,071 |
| Capital Expenditure | -183 | -94 | -44 | -1,312 | -1,038 |
| Free Cash Flow | -105,407 | -70,542 | -37,910 | -110,340 | -83,109 |